Irina Rivkind Koffler
Stock Analyst at Mizuho
(0)
# 4680
Out of 5,240 analysts
84
Total ratings
31.25%
Success rate
-19.47%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Evolus | Assumes: Buy | 30 | 9.74 | 208.01% | 4 | Sep 5, 2019 | |
Allergan | Downgrades: Neutral | 171 188 | n/a | n/a | 8 | Jun 26, 2019 | |
Journey Medical | Upgrades: Buy | 17 14 | 3.92 | 257.14% | 4 | Jun 6, 2019 | |
Jazz Pharmaceuticals | Maintains: Neutral | 146 148 | 122.63 | 20.69% | 6 | May 8, 2019 | |
Pacira BioSciences | Upgrades: Neutral | 29 38 | 20.41 | 86.18% | 4 | May 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 40 41 | 0.65 | 6207.69% | 7 | Mar 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 11 5 | n/a | n/a | 3 | Mar 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 29 22 | n/a | n/a | 3 | Dec 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 61 63 | 37.56 | 67.73% | 2 | Dec 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 21 | n/a | n/a | 6 | Nov 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 28 29 | 21.32 | 36.02% | 7 | Sep 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 9 | May 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 3 | May 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 17 0 | n/a | n/a | 6 | Dec 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 5 | Oct 3, 2017 |